Revenue (Annual) Chart

View Revenue (Annual) for ELXMF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Annual) Chart
Start Trial

Historical Revenue (Annual) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 23.63M
June 30, 2025 18.95M
June 30, 2024 15.28M
June 30, 2023 11.45M
June 30, 2022 9.703M
June 30, 2021 9.991M
June 30, 2020 8.56M
June 30, 2019 11.55M
June 30, 2018 61.40M
June 30, 2017 54.02M
June 30, 2016 53.06M
June 30, 2015 52.21M
June 30, 2014 49.92M
June 30, 2013 43.91M
Date Value
June 30, 2012 48.98M
June 30, 2011 42.51M
June 30, 2010 41.73M
June 30, 2009 42.88M
June 30, 2008 45.01M
June 30, 2007 34.85M
June 30, 2006 25.84M
June 30, 2005 20.25M
June 30, 2004 17.53M
June 30, 2003 15.10M
June 30, 2002 14.33M
June 30, 2001 0.00
June 30, 2000 0.0078M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
Cochlear Ltd. 1.582B
ImpediMed Ltd. 9.902M
Nanosonics Ltd. 137.87M
Somnomed Ltd. 77.61M
Imagion Biosystems Ltd. 0.00